![Frontiers | Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer? Frontiers | Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?](https://www.frontiersin.org/files/Articles/427647/fimmu-09-03107-HTML/image_m/fimmu-09-03107-g001.jpg)
Frontiers | Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?
![COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety | Nature Reviews Clinical Oncology COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-022-00610-8/MediaObjects/41571_2022_610_Fig1_HTML.png)
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety | Nature Reviews Clinical Oncology
![Cancer Treatment May Inhibit Immune Response to COVID-19 Vaccination - Infectious Disease Special Edition Cancer Treatment May Inhibit Immune Response to COVID-19 Vaccination - Infectious Disease Special Edition](https://www.idse.net/aimages/2022/COVIDmRNA_thumb.jpg)
Cancer Treatment May Inhibit Immune Response to COVID-19 Vaccination - Infectious Disease Special Edition
![COVID-19 vaccines for patients with cancer: benefits likely outweigh risks | Journal of Hematology & Oncology | Full Text COVID-19 vaccines for patients with cancer: benefits likely outweigh risks | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01046-w/MediaObjects/13045_2021_1046_Fig1_HTML.png)
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks | Journal of Hematology & Oncology | Full Text
![Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors - ScienceDirect Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419310440-gr1.jpg)
Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors - ScienceDirect
![Cancer Patients on Chemotherapy Likely Not Fully Protected by COVID-19 Vaccine | University of Arizona News Cancer Patients on Chemotherapy Likely Not Fully Protected by COVID-19 Vaccine | University of Arizona News](https://cdn.uanews.arizona.edu/s3fs-public/vaccine-header-image.jpg)
Cancer Patients on Chemotherapy Likely Not Fully Protected by COVID-19 Vaccine | University of Arizona News
![An immune cocktail therapy to realize multiple boosting of the cancer- immunity cycle by combination of drug/gene delivery nanoparticles | Science Advances An immune cocktail therapy to realize multiple boosting of the cancer- immunity cycle by combination of drug/gene delivery nanoparticles | Science Advances](https://www.science.org/cms/10.1126/sciadv.abc7828/asset/97e98b10-2a97-410e-b348-82821f2416e3/assets/graphic/abc7828-f1.jpeg)
An immune cocktail therapy to realize multiple boosting of the cancer- immunity cycle by combination of drug/gene delivery nanoparticles | Science Advances
![Booster shot improves immune response of chemotherapy patients; post-COVID depression helped by widely used drugs | Reuters Booster shot improves immune response of chemotherapy patients; post-COVID depression helped by widely used drugs | Reuters](https://www.reuters.com/resizer/hU5RG32zLjzDeVwAjbp-JMLbFFg=/1920x1920/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/24KJQCG5N5IT3JSPXN2TIVGSGE.jpg)
Booster shot improves immune response of chemotherapy patients; post-COVID depression helped by widely used drugs | Reuters
![Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial - The Lancet Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial - The Lancet](https://www.thelancet.com/cms/attachment/0d3d5972-77c1-4161-bbf6-a21c4ab51b4a/gr1.gif)
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial - The Lancet
![An ultrasound-driven immune-boosting molecular machine for systemic tumor suppression | Science Advances An ultrasound-driven immune-boosting molecular machine for systemic tumor suppression | Science Advances](https://www.science.org/cms/10.1126/sciadv.abj4796/asset/f275c8b8-b1de-4cbf-acd1-2d86f476697c/assets/images/large/sciadv.abj4796-f1.jpg)